Clinical trials
Cytomegalovirus Infections trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| St George's, University of London | 3 |
| Cell Medica Ltd | 2 |
| University College, London | 2 |
| AlloVir | 1 |
| Genentech, Inc. | 1 |
| Gilead Sciences | 1 |
| Hookipa Biotech GmbH | 1 |
| Hospital Universitario 12 de Octubre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytomegalovirus Infections | 26 |
| Acquired Immunodeficiency Syndrome | 3 |
| HIV Infections | 2 |
| Hearing Loss | 2 |
| Adenoviridae Infections | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Cytomegalovirus Retinitis | 1 |
| DNA Virus Infections | 1 |
| Epstein-Barr Virus Infections | 1 |
| Graft vs Host Disease | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.